The presence of TGFB1-expressing infected CD4+ T cells within the liver microenvironment provides an additional localized source of TGF-β, potentially amplifying pro-fibrotic signaling and contributing to NASH-like pathology in chronic infection. This evidence concerns the gene TGFB1 and metabolic dysfunction-associated steatohepatitis.